Bosulif 100 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F57KE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,035
Award facts
- Contract value 100% obligated
- $18,034.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BOSULIF 100 mg tablets (120-count) valued at $18,034.86 under a firm fixed-price contract. The award, issued on January 15, 2026, with an ultimate completion date of February 6, 2026, represents a non-set-aside, competitively awarded delivery order. BOSULIF is a prescription oncology medication used in the treatment of chronic myeloid leukemia. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's supply chain.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical support vehicle through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC relationship with DLA valued at up to $999,999,999 through December 31, 2031. These contracts demonstrate the company's established capability to efficiently fulfill government requirements for essential pharmaceutical commodities across multiple therapeutic domains required by military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F57KE?
SPE2DR26F57KE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F57KE worth?
The government has obligated $18,035 on SPE2DR26F57KE.
Is contract SPE2DR26F57KE an order under another contract?
Yes. SPE2DR26F57KE is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57KE competed?
The extent of competition for SPE2DR26F57KE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award